The ESMO Gastrointestinal Cancers Congress 2026 is set to be a pivotal event where the forefront of research and innovation in gastrointestinal cancers will be showcased. Attendees will be immersed in a wealth of knowledge through groundbreaking presentations, multidisciplinary tumour boards, and engaging controversy sessions. The latest research findings, innovative therapeutic strategies, and emerging technologies that are shaping the future of GI cancer treatment will be explored in depth. This congress offers an unparalleled opportunity for those in the field to stay informed about cutting-edge advancements.

A comprehensive programme is planned, covering a wide spectrum of topics essential to the treatment of GI malignancies. From molecular prevention and diagnosis to precision therapy and patient-centered care approaches, the congress will provide a holistic view of the current landscape and future directions in GI cancer treatment. This diverse array of topics ensures that participants will gain a well-rounded understanding of the challenges and opportunities within the field, enhancing their ability to contribute effectively to the global fight against these complex diseases.

Networking opportunities will be abundant, enabling connections among peers and facilitating the exchange of ideas and best practices. These interactions are crucial for fostering collaboration and innovation, as they allow for the sharing of diverse perspectives and experiences. By participating in the ESMO Gastrointestinal Cancers Congress 2026, individuals will be able to engage with leading experts and healthcare professionals, contributing to the global effort in improving outcomes for patients with GI cancers. This congress promises to be an invaluable experience for those committed to advancing oncological knowledge and practice.